Cargando…
High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK(Ca)-Channel Activity and Inhibits I(K(M)) or I(h)
GAL-021 has recently been developed as a novel breathing control modulator. However, modifications of ionic currents produced by this agent remain uncertain, although its efficacy in suppressing the activity of big-conductance Ca(2+)-activated K(+) (BK(Ca)) channels has been reported. In pituitary t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072225/ https://www.ncbi.nlm.nih.gov/pubmed/31991782 http://dx.doi.org/10.3390/biom10020188 |
_version_ | 1783506356932706304 |
---|---|
author | Lu, Te-Ling Gao, Zi-Han Li, Shih-Wei Wu, Sheng-Nan |
author_facet | Lu, Te-Ling Gao, Zi-Han Li, Shih-Wei Wu, Sheng-Nan |
author_sort | Lu, Te-Ling |
collection | PubMed |
description | GAL-021 has recently been developed as a novel breathing control modulator. However, modifications of ionic currents produced by this agent remain uncertain, although its efficacy in suppressing the activity of big-conductance Ca(2+)-activated K(+) (BK(Ca)) channels has been reported. In pituitary tumor (GH(3)) cells, we found that the presence of GAL-021 decreased the amplitude of macroscopic Ca(2+)-activated K(+) current (I(K(Ca))) in a concentration-dependent manner with an effective IC(50) of 2.33 μM. GAL-021-mediated reduction of I(K(Ca)) was reversed by subsequent application of verteporfin or ionomycin; however, it was not by that of diazoxide. In inside-out current recordings, the addition of GAL-021 to the bath markedly decreased the open-state probability of BK(Ca) channels. This agent also resulted in a rightward shift in voltage dependence of the activation curve of BK(Ca) channels; however, neither the gating charge of the curve nor single-channel conductance of the channel was changed. There was an evident lengthening of the mean closed time of BK(Ca) channels in the presence of GAL-021, with no change in mean open time. The GAL-021 addition also suppressed M-type K(+) current with an effective IC(50) of 3.75 μM; however, its presence did not alter the amplitude of erg-mediated K(+) current, or mildly suppressed delayed-rectifier K(+) current. GAL-021 at a concentration of 30 μM could also suppress hyperpolarization-activated cationic current. In HEK293T cells expressing α-hSlo, the addition of GAL-021 was also able to suppress the BK(Ca)-channel open probabilities, and GAL-021-mediated suppression of BK(Ca)-channel activity was attenuated by further addition of BMS-191011. Collectively, the GAL-021 effects presented herein do not exclusively act on BK(Ca) channels and these modifications on ionic currents exert significant influence on the functional activities of electrically excitable cells occurring in vivo. |
format | Online Article Text |
id | pubmed-7072225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70722252020-03-19 High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK(Ca)-Channel Activity and Inhibits I(K(M)) or I(h) Lu, Te-Ling Gao, Zi-Han Li, Shih-Wei Wu, Sheng-Nan Biomolecules Article GAL-021 has recently been developed as a novel breathing control modulator. However, modifications of ionic currents produced by this agent remain uncertain, although its efficacy in suppressing the activity of big-conductance Ca(2+)-activated K(+) (BK(Ca)) channels has been reported. In pituitary tumor (GH(3)) cells, we found that the presence of GAL-021 decreased the amplitude of macroscopic Ca(2+)-activated K(+) current (I(K(Ca))) in a concentration-dependent manner with an effective IC(50) of 2.33 μM. GAL-021-mediated reduction of I(K(Ca)) was reversed by subsequent application of verteporfin or ionomycin; however, it was not by that of diazoxide. In inside-out current recordings, the addition of GAL-021 to the bath markedly decreased the open-state probability of BK(Ca) channels. This agent also resulted in a rightward shift in voltage dependence of the activation curve of BK(Ca) channels; however, neither the gating charge of the curve nor single-channel conductance of the channel was changed. There was an evident lengthening of the mean closed time of BK(Ca) channels in the presence of GAL-021, with no change in mean open time. The GAL-021 addition also suppressed M-type K(+) current with an effective IC(50) of 3.75 μM; however, its presence did not alter the amplitude of erg-mediated K(+) current, or mildly suppressed delayed-rectifier K(+) current. GAL-021 at a concentration of 30 μM could also suppress hyperpolarization-activated cationic current. In HEK293T cells expressing α-hSlo, the addition of GAL-021 was also able to suppress the BK(Ca)-channel open probabilities, and GAL-021-mediated suppression of BK(Ca)-channel activity was attenuated by further addition of BMS-191011. Collectively, the GAL-021 effects presented herein do not exclusively act on BK(Ca) channels and these modifications on ionic currents exert significant influence on the functional activities of electrically excitable cells occurring in vivo. MDPI 2020-01-25 /pmc/articles/PMC7072225/ /pubmed/31991782 http://dx.doi.org/10.3390/biom10020188 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lu, Te-Ling Gao, Zi-Han Li, Shih-Wei Wu, Sheng-Nan High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK(Ca)-Channel Activity and Inhibits I(K(M)) or I(h) |
title | High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK(Ca)-Channel Activity and Inhibits I(K(M)) or I(h) |
title_full | High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK(Ca)-Channel Activity and Inhibits I(K(M)) or I(h) |
title_fullStr | High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK(Ca)-Channel Activity and Inhibits I(K(M)) or I(h) |
title_full_unstemmed | High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK(Ca)-Channel Activity and Inhibits I(K(M)) or I(h) |
title_short | High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK(Ca)-Channel Activity and Inhibits I(K(M)) or I(h) |
title_sort | high efficacy by gal-021: a known intravenous peripheral chemoreceptor modulator that suppresses bk(ca)-channel activity and inhibits i(k(m)) or i(h) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072225/ https://www.ncbi.nlm.nih.gov/pubmed/31991782 http://dx.doi.org/10.3390/biom10020188 |
work_keys_str_mv | AT luteling highefficacybygal021aknownintravenousperipheralchemoreceptormodulatorthatsuppressesbkcachannelactivityandinhibitsikmorih AT gaozihan highefficacybygal021aknownintravenousperipheralchemoreceptormodulatorthatsuppressesbkcachannelactivityandinhibitsikmorih AT lishihwei highefficacybygal021aknownintravenousperipheralchemoreceptormodulatorthatsuppressesbkcachannelactivityandinhibitsikmorih AT wushengnan highefficacybygal021aknownintravenousperipheralchemoreceptormodulatorthatsuppressesbkcachannelactivityandinhibitsikmorih |